- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Mankind Pharma has announced a board meeting on Thursday, July 31, 2025. The agenda includes considering and approving the financial results for the quarter ended June 30, 2025. The Board will also evaluate the potential declaration of an interim dividend for the financial year 2025-26. Investors should note the trading window for the company's securities remains closed until August 2, 2025.